Articles By Jack Cush, MD
The Inflammation Reflex (5.20.2022)
By Jack Cush, MD
20 May 2022
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week, neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA.
Read Article
Biologic Persistence in Psoriatic Arthritis and Psoriasis
By Jack Cush, MD
19 May 2022
Two recent studies examined the durability and persistence of biologic agents in patients with psoriasis (PSO) and psoriatic arthritis (PsA) and while some differences were noted overall persistence was low 3 years later.
Read Article
Inflammatory Arthritis Spread by ATP and Neural Crosstalk
By Jack Cush, MD
19 May 2022
A novel study from the Journal of Experimental Medicine suggests that a reflex neural signaling at sites of inflammation may lead to spread to other inflammatory sites via and ATP-mediated neural crosstalk.
Read Article
Relevance of Raynaud’s in Systemic Sclerosis
By Jack Cush, MD
18 May 2022
Raynaud’s phenomenon (RP) is integral to the diagnosis and management of systemic sclerosis (SSc) patients; a recent analysis suggests that RP should be characterized based on color change and the presence of other symptoms to know whether RP portends more serious manifestations.
Read Article
RNL 2022: Spondyloarthritis Spectrum
By Jack Cush, MD
18 May 2022
This RheumNow Live 2022 session features highlights from lectures on Spondyloarthritis. - Microbiome in Spondyloathritis - Jose Scher, MD - Axial Psoriatic Arthritis - Philip Mease, MD - Juvenile Spondyloathritis - Pamela Weiss, MD
Read Article
Rising Incidence of Systemic Lupus Erythematosus
By Jack Cush, MD
17 May 2022
Data from Olmstead county, MN over the past four decades shows that the incidence and prevalence of systemic lupus erythematosus (SLE) is increasing. SLE was diagnosed using the EULAR/ACR criteria and looked at patients seen between 1976–2018.
Read Article
Multimorbidity Burden in Rheumatoid Arthritis
By Jack Cush, MD
17 May 2022
Crowson and colleagues at the Mayo Clinic have shown that rheumatoid arthritis (RA) patients have a higher prevalence of multimorbidity with as many as 44 different morbidities of interest in RA.
Read Article
Acute Inflammatory Responses Needed to Resolve Chronic Pain
By Jack Cush, MD
16 May 2022
Science Translational Medicine has published results of a Canadian study of low back pain (LBP) suggests that pain control by anti-inflammatory treatments might have negative effects on pain duration and may be counterproductive for long-term pain outcomes.
Read Article
Bimekizumab Development Delayed by FDA
By Jack Cush, MD
16 May 2022
UCB announced they have received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) for bimekizumab for the treatment of adults with moderate to severe plaque psoriasis (PSO).
Read ArticleMethotrexate Monitoring (5.13.2022)
By Jack Cush, MD
13 May 2022
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Bad news for digitial ulcers in Systemic sclerosis, Readmissions in Lupus and Thrombocytopenia in APL patients.
Read Article